Tissue dielectric property differentiation via radiofrequency electromagnetic field analysis

"Tissue dielectric property differentiation via radiofrequency electromagnetic field analysis" is **not a molecular target, receptor, enzyme, or protein**. Instead, it refers to the process of distinguishing and characterizing biological tissues based on their **dielectric properties**—specifically permittivity and conductivity—when exposed to radiofrequency (RF) electromagnetic fields. This approach is widely used in medical imaging modalities such as MRI and microwave imaging to exploit differences in how various tissues interact with electric and magnetic components of RF fields. The technique relies on the fact that different tissues have distinct frequency-dependent dielectric parameters due to variations in water content, ionic composition, and cellular structure. These properties can be measured using models like the 4-Cole-Cole model across a wide frequency range (10 Hz–100 GHz).\nThe main applications are **diagnostic** rather than therapeutic; this method helps improve image contrast or identify pathological changes by mapping spatial variations in tissue electrical properties. It does not represent a druggable biological target but rather an analytical/engineering concept used for non-invasive assessment of tissue composition or state.\nThere are no known drugs that "interact" with this "target," nor is there any mechanism of action relevant for pharmacology. Safety concerns relate primarily to potential heating effects from RF exposure during diagnostic procedures if energy absorption exceeds safe limits.\nIn summary, this entry describes a **physical measurement principle**, not a canonical molecular entity suitable for structured drug-target databases.

Other names

Dielectric property analysis of tissueRF dielectric tissue differentiationElectromagnetic field-based tissue characterization